Clearside Biomedical, Inc. (CLSD) Return On Equity % [USD] 2017 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Clearside Biomedical, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2024.
  • Clearside Biomedical, Inc. Return On Equity for the quarter ending March 31, 2024 was 252 %.
  • Clearside Biomedical, Inc. annual Return On Equity for 2023 was 419 %.
  • Clearside Biomedical, Inc. annual Return On Equity for 2022 was -153 %, a 9477% decline from 2021.
  • Clearside Biomedical, Inc. annual Return On Equity for 2021 was 1.63 %.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 252 +494 Jan 1, 2024 Mar 31, 2024
Q4 2023 419 +572 Oct 1, 2023 Dec 31, 2023
Q3 2023 3.31 K +3.32 K Jul 1, 2023 Sep 30, 2023
Q2 2023 -534 -528 -9106% Apr 1, 2023 Jun 30, 2023
Q1 2023 -242 -243 -78078% Jan 1, 2023 Mar 31, 2023
Q4 2022 -153 -155 -9477% Oct 1, 2022 Dec 31, 2022
Q3 2022 -16.1 +146 +90% Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.8 +167 +96.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 0.31 +220 Jan 1, 2022 Mar 31, 2022
Q4 2021 1.63 +212 Oct 1, 2021 Dec 31, 2021
Q3 2021 -162 -8.31 -5.42% Jul 1, 2021 Sep 30, 2021
Q2 2021 -173 +16.6 +8.74% Apr 1, 2021 Jun 30, 2021
Q1 2021 -220 -54.9 -33.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -210 +36.2 +14.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 -153 +163 +51.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -189 +86.3 +31.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -165 +51.8 +23.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -247 -96.2 -64% Oct 1, 2019 Dec 31, 2019
Q3 2019 -316 -174 -122% Jul 1, 2019 Sep 30, 2019
Q2 2019 -276 -139 -102% Apr 1, 2019 Jun 30, 2019
Q1 2019 -217 -85.6 -65.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -150 -19.2 -14.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -142 -51.8 -57.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -137 -71.1 -108% Apr 1, 2018 Jun 30, 2018
Q1 2018 -131 -78.2 -147% Jan 1, 2018 Mar 31, 2018
Q4 2017 -131 Oct 1, 2017 Dec 31, 2017
Q3 2017 -90.7 Jul 1, 2017 Sep 30, 2017
Q2 2017 -65.8 Apr 1, 2017 Jun 30, 2017
Q1 2017 -53.2 Jan 1, 2017 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.